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Background:  Prior studies have suggested that patients with diabetes mellitus and coronary artery disease have impaired angina perception and 
experience silent ischemia. Aim: The aim of this study was to describe symptom presentation and identify the predictors of angina in clinically stable 
patients with type 2 diabetes mellitus and coronary artery disease (CAD)documented by coronary angiography. 
Methods:  Patient reported symptoms of angina, anginal equivalents or an absence of symptoms were obtained at entry into the Bypass 
Angioplasty Revascularization Investigation 2 Diabetes trial (BARI 2D). Cochran-Mantel-Haenszel chi-square analysis and stepwise logistic regression 
were used. 
Results:  In 2319 patients, classic angina (CA) at baseline was present in 19%, anginal equivalents in 21%, both angina and anginal equivalents 
in 42% and no symptoms were noted in 18%. Significant associations with CA stratified by prior revascularization status were noted for age, sex, 
region/country, current tobacco use, age at diabetes mellitus diagnosis and regular exercise. However, in the multivariable logistic regression 
analysis only a history of hypertension (OR 1.34, 95% CI 1.07-1.67, p=0.011) and previous percutaneous coronary intervention ( OR 1.61, 95% 
CI 1.29-2.02, p<0.0001) were independently associated with an increase in the odds of classic angina at baseline. Male sex (OR 0.74, 95% CI 
0.61-0.90, p=0.0025), age >60 years (OR 0.65, 95% CI 0.54-0.77, p<0.0001), current exercise ( OR 0.75, 95% CI 0.62-0.91, p=0.0035) and 
thiazolidinedione use (OR 0.60, 95% CI 0.49-0.75, p<0.0001) had a decreased odds of an association with classic angina. 
Conclusions:  In a cohort of clinically stable patients with type 2 diabetes mellitus and CAD documented by coronary angiography enrolled in the 
BARI 2D trial greater than 80% had documented symptoms at baseline. Approximately 60% had angina. Significant predictors of angina included 
a prior history of hypertension and percutaneous coronary intervention. Future studies of long term outcomes associated with these features at 
baseline should facilitate clinical decision making needed for optimal management of such patients.
